明報新聞網

恒瑞醫藥與Braveheart Bio達成協議股價曾升逾3%

5 9 月, 2025

One Min Read

11 Views

恒瑞醫藥(1276)公布，與Braveheart Bio達成協議，將1類創新藥HRS-1893項目有償許可給Braveheart Bio。

原文: https://finance.mingpao.com/fin/instantf/20250905/1757037466947/%e6%81%92%e7%91%9e%e9%86%ab%e8%97%a5%e8%88%87braveheart-bio%e9%81%94%e6%88%90%e5%8d%94%e8%ad%b0-%e8%82%a1%e5%83%b9%e6%9b%be%e5%8d%87%e9%80%be3

Last Update: 5 9 月, 2025

Written By

Other Articles

Previous

Qantas tightens purse strings on executive pay after data breach fallout

Next

《談國論企－黎偉成》京津盛會盡顯中國發展模式受歡迎

Related Posts

明報新聞網

天氣｜天文台：大致多雲　日間部分時間有陽光

1 Min Read

明報新聞網

短片：西班牙葡萄牙恢復供電　停電期間火車、飛機停運

1 Min Read

明報新聞網

抽象派畫家Mark Rothko 4.4億元作品荷蘭展出　遭小孩刮花

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept